The researchers engineered a virus that infected a patient's T-cells, a type of white blood cell, and carried instructions to bind to cancer cells and ultimately kill them.
In the lab, they infected those cells with a virus carrying genes that create T-cell receptors, essentially homing devices for, in this case, melanoma.